1 / 27

S 2007 BIOC 3406

S 2007 BIOC 3406. 02-13-07. Management of Inventories of Glucose and Glycogen. Coordinated regulation of Glycolysis and Gluconeogenesis Coordinated regulation of glycogen synthesis and breakdown. Coordinate Regulation of Glycolysis and Gluconeogenesis. Three control points

oona
Télécharger la présentation

S 2007 BIOC 3406

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. S 2007 BIOC 3406 02-13-07

  2. Management of Inventories of Glucose and Glycogen • Coordinated regulation of Glycolysis and Gluconeogenesis • Coordinated regulation of glycogen synthesis and breakdown

  3. Coordinate Regulation of Glycolysis and Gluconeogenesis • Three control points • Direction of flow through reactions coordinately turned one way or the other, as opposed to • Both on at the same time, controlling by turning one or the other up (futile or substrate cycling) ATP + F 6P  ADP + F 1,6BP F 1,6BP + H2O  F 6P + Pi ATP + H2O  ADP + Pi PFK-1 H neg FBPase-1 H neg work wasted H neg

  4. Glycolysis

  5. Hexokinase • Muscle (Hexokinases I-III) • Primary isozyme (II) has KM ~ 0.1 mM (cf normal blood glucose ~ 5 mM (90 mg/dl)) • Continuous push of glucose toward glycolysis, enzyme operating at top capacity • Inhibition by glucose 6-phosphate (end product inhibition)

  6. Hexokinase • Liver • Hexokinase IV has KM ~ 10 mM (cf normal blood glucose ~ 5 mM (90 mg/dl)) • Rapid equilibration with blood glucose (GLUT-2) • Blood glucose immediately and directly affects efficiency of enzyme • High BG glucose  G 6P • Low BG glucose  no reaction • When BG low, Hexokinase IV sequestered in nucleus and inhibited by protein • G 6P NOT inhibitory • F 6P role

  7. Phosphofructokinase-1 • Glucose “committed” to glycolysis at this step • ATP allosteric inhibitor (even though a substrate) • ADP, AMP promoters • Citrate (condensation product of acetyl CoA and OAA) increases action of ATP • Fructose 2,6-bisphosphate STRONG activator

  8. Pyruvate kinase • ATP, acetyl-CoA, long chain fatty acids, alanine, allosteric inhibitors • L form inactivated by phosphorylation (phosphorylation potentiated via cAMP-dependent protein kinase, or protein kinase A) • L form activated by dephosphorylation (protein phosphatase) • M form activated by cAMP • F 1,6BP activator

  9. Gluconeogenesis

  10. Pyruvate Carboxylase • PDH complex converts pyruvate to Acetyl-CoA (AcSCoA) • AcSCoA inhibits PDH (oxidative phosphorylation slows, NADH/NAD+ increases, CAC slows, AcSCoA builds up, stimulates kinase which deactivates PDH) • Pyruvate carboxylase converts pyruvate to oxaloacetate • AcSCoA allosterically activates pyruvate carboxylase

  11. Coordinate regulation of FBPase-1 and PFK-1 • ATP, ADP, AMP, citrate • F 2,6BP

More Related